Evaluation of pulsed Doppler tissue velocity imaging for assessing systolic function of murine global heart failure

J Am Soc Echocardiogr. 2005 Feb;18(2):148-54. doi: 10.1016/j.echo.2004.08.038.

Abstract

The feasibility of Doppler tissue imaging (DTI) for assessing global systolic function has not been determined in small animals, particularly at near-conscious heart rates. Therefore, we compared DTI measurements with conventional M-mode-derived fractional shortening in murine global left ventricular systolic dysfunction induced by intraperitoneal doxorubicin (Dox) injection. In all, 13 female C57BL mice received 20 mg/kg of Dox and 12 mice received saline injection (controls). DTI signals were obtained from the inferior wall through parasternal short-axis views. The heart rate was kept at near-conscious level throughout DTI measurements (approximately 500/min). Left ventricular systolic dysfunction was detectable by measurements of fractional shortening from 4 to 14 days after Dox administration. Among DTI measurements, peak systolic velocity and time to peak systolic velocity decreased from 4 to 14 days after Dox injection. Our results indicate that these new DTI measurements appear feasible to assess global left ventricular systolic dysfunction in mice.

Publication types

  • Comparative Study
  • Evaluation Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic
  • Blood Flow Velocity / drug effects
  • Disease Models, Animal
  • Doxorubicin
  • Echocardiography, Doppler, Pulsed*
  • Female
  • Heart Failure / chemically induced
  • Heart Failure / diagnostic imaging*
  • Heart Failure / physiopathology*
  • Mice
  • Mice, Inbred C57BL
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / pathology
  • Observer Variation
  • Reproducibility of Results
  • Stroke Volume / drug effects
  • Systole / drug effects
  • Ventricular Dysfunction, Left / diagnostic imaging*
  • Ventricular Dysfunction, Left / physiopathology*

Substances

  • Antibiotics, Antineoplastic
  • Doxorubicin